Oct. 13, 2021, 10:51 a.m. EDT
Want to see how this story relates to your watchlist?
Just add items to create a watchlist now:
Shares of Progenity Inc. gained 4.9% in trading on Wednesday after the company said it received four patents from the U.S. Patent and Trademark Office related to its ingestible technologies that can be used to deliver medicine to the gastrointestinal tract. Progenity's stock has tumbled 56.0% so far this year, while the S&P 500 /zigman2/quotes/210599714/realtime SPX +2.47% is up 15.8%.
Markets Reversed Their Losing Streaks. The Fed Might Avoid Inflicting More Pain.
Chewy’s Upcoming Earnings Might Not Be So Great. Why the Stock Could Still Be OK.
Why the Dow finally bounced — and what it will take to convince investors it’s for real
So This Is What a Winning Week Feels Like. Don’t Get Used to It.
From Davos to Wall Street, Pessimism Is the Message of the Moment
Snowflake Stock Looks Attractive—2 Years After Its Crazy IPO
These 7 Tech Stocks Have Taken a Beating. They Could Be Bargains.
Despite focus on Amazon worker issues, no shareholder proposals approved
Crypto’s Future Is Nothing Like You Imagined. Here’s What Lies Ahead.
Monkeypox symptoms and how to tell if you have it: what you need to know
Avoiding Recession May Require Moving the Inflation Goal Post
Alerts
Virtual Stock Exchange
Copyright © 2022 MarketWatch, Inc. All rights reserved.
By using this site, you agree to the Subscriber Agreement & Terms of Use
Privacy Notice and
Cookie Notice ().
Do Not Sell My Personal Information
Intraday Data provided by FACTSET and subject to terms of use. Historical and current end-of-day data provided by FACTSET. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
Add to watchlist
